Article

November 14, 2012

FDA Seeks More Authority Over Compounding Pharmacies

The Food and Drug Administration said its authority over compounding pharmacies is limited and needs to be strengthened in the wake of a multistate meningitis outbreak caused by tainted steroid injections produced by a pharmacy in Massachusetts.

The FDA has come under scrutiny for its oversight of the New England Compounding Center, the Framingham, Mass.-based compounding pharmacy that is responsible for distributing contaminated vials of preservative-free methylprednisolone acetate.

Read the full story:http://bit.ly/XF0gF0

Source: ModernHealthcare.com

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos

Karen Vo talks about antibullying campaigns and pediatric patients with derm conditions

Screenshot of a webinar panel discussion with Viet Le, PA-C; Nathan Wong, PhD, MPH; Alison Bailey, MD; and Martha Gulati, MD, MS

Mehmet Oz, MD, MBA

Hira Ghani, DO, discusses underdiagnosed skin conditions in children

Nicole Bajic, MD

World Hepatitis Day graphic | Image Credit: uazzal - stock.adobe.com

Related Content

SDOH | Image credit: STOATPHOTO - stock.adobe.com.

Published: July 26th 2025 | Updated: July 26th 2025

Addressing SDOH in Pediatric Dermatology to Improve Outcomes

At the Society for Pediatric Dermatology Annual Meeting, Sarah Coates, MD, FAAD, highlights how social drivers shape pediatric skin health and how clinicians can respond.

July 24th 2025

High Costs, Coverage Variability Limit Access to Incretin Mimetics for Weight Management

Brooke McCormick Stephen Lott, PharmD, MS Jonathan Gabison, MD, DABOM

This Managed Care Cast episode explores how high costs and inconsistent insurance coverage for incretin mimetics impact obesity management and patient care.

Early-onset breast cancer found to be associated with certain hormone therapy usage in younger women. | Image Credit: Chinnapong - stock.adobe.com

July 26th 2025

Hormone Therapy Use May Impact Early-Onset Breast Cancer Risk

Sabrina McCrear

Early-onset breast cancer was associated with hormone therapy usage in younger women in a recent study.

Managed Care Cast

Published: July 15th 2025 | Updated: July 15th 2025

Navigating Risk, Treatment, and Reimbursement in Precision Oncology: Sadie Dobrozsi, MD

Giuliana Grossi Sadie Dobrozsi, MD, MS Interview by Mary Caffrey

Sadie Dobrozsi, MD, of Evolent, discusses how predictive genomics is pushing cancer care into a new era of personalization

PA form | Image: Adobe Stock

July 25th 2025

KFF Survey: Most Consumers Find Prior Authorization Is a Major Problem

A new survey reveals widespread consumer frustration with prior authorization, highlighting the need for urgent reform in insurance coverage.

anaphylaxis training. | Image Credit: Flex_Point_Security - stock.adobe.com

July 25th 2025

AllergyAware E-Learning Training Program Boosts Anaphylaxis Preparedness in School Staff

Cameron Santoro

The AllergyAware e-learning course effectively trained school personnel on anaphylaxis management, significantly improving their knowledge and confidence in using epinephrine auto-injectors, despite some technical and pacing issues reported by users.

Related Content

SDOH | Image credit: STOATPHOTO - stock.adobe.com.

Published: July 26th 2025 | Updated: July 26th 2025

Addressing SDOH in Pediatric Dermatology to Improve Outcomes

At the Society for Pediatric Dermatology Annual Meeting, Sarah Coates, MD, FAAD, highlights how social drivers shape pediatric skin health and how clinicians can respond.

July 24th 2025

High Costs, Coverage Variability Limit Access to Incretin Mimetics for Weight Management

Brooke McCormick Stephen Lott, PharmD, MS Jonathan Gabison, MD, DABOM

This Managed Care Cast episode explores how high costs and inconsistent insurance coverage for incretin mimetics impact obesity management and patient care.

Early-onset breast cancer found to be associated with certain hormone therapy usage in younger women. | Image Credit: Chinnapong - stock.adobe.com

July 26th 2025

Hormone Therapy Use May Impact Early-Onset Breast Cancer Risk

Sabrina McCrear

Early-onset breast cancer was associated with hormone therapy usage in younger women in a recent study.

Managed Care Cast

Published: July 15th 2025 | Updated: July 15th 2025

Navigating Risk, Treatment, and Reimbursement in Precision Oncology: Sadie Dobrozsi, MD

Giuliana Grossi Sadie Dobrozsi, MD, MS Interview by Mary Caffrey

Sadie Dobrozsi, MD, of Evolent, discusses how predictive genomics is pushing cancer care into a new era of personalization

PA form | Image: Adobe Stock

July 25th 2025

KFF Survey: Most Consumers Find Prior Authorization Is a Major Problem

A new survey reveals widespread consumer frustration with prior authorization, highlighting the need for urgent reform in insurance coverage.

anaphylaxis training. | Image Credit: Flex_Point_Security - stock.adobe.com

July 25th 2025

AllergyAware E-Learning Training Program Boosts Anaphylaxis Preparedness in School Staff

Cameron Santoro

The AllergyAware e-learning course effectively trained school personnel on anaphylaxis management, significantly improving their knowledge and confidence in using epinephrine auto-injectors, despite some technical and pacing issues reported by users.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions